Erasca reports Q3 2026 results, Fast Track status for ERAS-0015 in pancreatic cancerNov 12Quarterly updateERAS-0015Erasca, Inc.
Emergent BioSolutions cuts 2026 revenue and EBITDA guidance as Q3 sales fall 52%Nov 2Quarterly updateAmgenAprea Therapeutics
Erasca updates ERAS-0015 data, plans registration-enabling trials, reports Q2 2026 resultsAug 11Quarterly updateERAS-0015Erasca, Inc.
Amgen posts results for three rocatinlimab Phase 3 trials, plus CodeBreak300 and AMG 133 updatesJul 24Weekly roundup, 5 itemsAmgenmaridebart cafraglutide